Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women

被引:55
作者
Zhao, H. -Y. [1 ]
Liu, J. -M. [1 ]
Ning, G. [1 ]
Zhao, Y. -J. [1 ]
Chen, Y. [1 ]
Sun, L. -H. [1 ]
Zhang, L. -Z. [1 ]
Xu, M. -Y. [1 ]
Chen, J. -L. [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metabol Dis, Ruijin Hosp, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
bone mineral density; insulin-like growth factor-I(IGF-I); OPG; RANKL;
D O I
10.1007/s00198-007-0440-y
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Serum IGF-I level was negatively correlated with OPG and OPG/RANKL ratio, but positively correlated with RANKL. Serum OPG level in the highest quintile of IGF-I was significantly lower than that in the lowest. We conclude that the effect of IGF-I on bone remodeling may be mediated by the OPG/RANKL system. Introduction Insulin-like growth factor I (IGF-I) is an important factor in coupling bone remodeling, activating both formation and resorption. Compared with the many studies on the role of IGF-I in bone formation, the information regarding its effects on bone resorption is limited and conflicting. The balance of the two peptides produced by osteoblasts, osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand (RANKL), is critical for the bone resorption process. Our study was designed to analyze the relationships of serum concentrations of IGF-I with OPG, RANKL, OPG/RANKL ratio as well as BMDs in healthy Chinese women. Methods BMDs at lumbar spine and proximal femur in 504 pre- and postmenopausal women were measured by DXA. Serum levels of IGF-I, OPG and RANKL were also measured. Pearson's correlation and partial correlation analysis, ANOVA, covariance analysis and stepwise multiple regression analysis were used as appropriate. Results Age was negatively correlated with serum levels of IGF-I (r=-0.702, p < 0.001). IGF-I was negatively correlated with OPG and OPG/RANKL ratio, but positively correlated with RANKL. The relationship between IGF-I and BMDs disappeared after adjustment for age. In postmenopausal women, IGF-I was lower in women with osteoporosis than in those with normal BMD (p=0.056), but no differences were found among OPG, RANKL and OPG/RANKL ratio. Serum levels of OPG in the highest quintile of IGF-I were significantly lower than those in the lowest quintile of IGF-I, while no difference was found in RANKL. In the multiple regression analysis model, serum levels of IGF-I were the main determinants of the bone mass in Chinese women. Conclusions In conclusion, the relationship between decreasing IGF-I and BMDs in healthy Chinese women influenced by age, whereas the effect of IGF-I on bone remodeling (bone resorption) may be mediated by the OPG/RANKL system.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 36 条
[1]
The skeletal structure of insulin-like growth factor I-deficient mice [J].
Bikle, D ;
Majumdar, S ;
Laib, A ;
Powell-Braxton, L ;
Rosen, C ;
Beamer, W ;
Nauman, E ;
Leary, C ;
Halloran, B .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (12) :2320-2329
[2]
Leptin reduces ovariectomy-induced bone loss in rats [J].
Burguera, B ;
Hofbauer, LC ;
Thomas, T ;
Gori, F ;
Evans, GL ;
Khosla, S ;
Riggs, BL ;
Turner, RT .
ENDOCRINOLOGY, 2001, 142 (08) :3546-3553
[3]
Insulin-like growth factors and osteoporosis [J].
Canalis, E .
BONE, 1997, 21 (03) :215-216
[4]
Characterization and function of the receptor for IGF-I in human preosteoclastic cells [J].
Fiorelli, G ;
Formigli, L ;
Orlandini, SZ ;
Gori, F ;
Falchetti, A ;
Morelli, A ;
Tanini, A ;
Benvenuti, S ;
Brandi, ML .
BONE, 1996, 18 (03) :269-276
[5]
One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women [J].
Friedlander, AL ;
Butterfield, E ;
Moynihan, S ;
Grillo, J ;
Pollack, M ;
Holloway, L ;
Friedman, L ;
Yesavage, J ;
Matthias, DF ;
Lee, S ;
Marcus, R ;
Hoffman, AR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1496-1503
[6]
IL-6, LIF, and TNF-α regulation of GM-CSF inhibition of osteoclastogenesis in vitro [J].
Gorny, G ;
Shaw, A ;
Oursler, MJ .
EXPERIMENTAL CELL RESEARCH, 2004, 294 (01) :149-158
[7]
OSTEOBLASTS MEDIATE INSULIN-LIKE GROWTH-FACTOR-I AND GROWTH-FACTOR-II STIMULATION OF OSTEOCLAST FORMATION AND FUNCTION [J].
HILL, PA ;
REYNOLDS, JJ ;
MEIKLE, MC .
ENDOCRINOLOGY, 1995, 136 (01) :124-131
[8]
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis [J].
Hofbauer, LC ;
Gori, F ;
Riggs, BL ;
Lacey, DL ;
Dunstan, CR ;
Spelsberg, TC ;
Khosla, S .
ENDOCRINOLOGY, 1999, 140 (10) :4382-4389
[9]
JIAN GJ, 2000, J BONE MINER RES, V15, pS157
[10]
Minireview: The OPG/RANKL/RANK system [J].
Khosla, S .
ENDOCRINOLOGY, 2001, 142 (12) :5050-5055